$0.59
0.00 (0%)
Avalon Pharmaceuticals, Inc. (NASDAQ:AVRX)
CAPS Rating:
A biopharmaceutical company which is focused on the discovery and development of potential first-in-class cancer therapeutics.
No players have picked AVRX yet. Tell us why you think AVRX will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
